Fidelity Investments’s Opiant Pharmaceuticals, Inc. Common Stock OPNT Stock Holding History

Fidelity Investments’s Portfolio OPNT Stock Details OPNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-200	Closed	-$2K	–	5098
2021 Q1	$2K	Hold	200	–	–	﹤0.01%	3771
2020 Q4	$2K	Hold	200	–	–	﹤0.01%	3630
2020 Q3	$1K	Buy	200 +50	+33%	+$444	﹤0.01%	3617
2020 Q2	$1K	Hold	150	–	–	﹤0.01%	3518
2020 Q1	$1K	Buy	150 +75	+100%	+$898	﹤0.01%	3553
2019 Q4	$1K	Buy	+75	New	+$1.09K	﹤0.01%	3711
2019 Q2	–	Sell	-76	Closed	-$1K	–	4304
2019 Q1	$1K	Buy	+76	New	+$1.11K	﹤0.01%	3539

Other funds holding OPNT

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACA

Apis Capital Advisors New York $648M AUM 302.67% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

PCM

Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments's OPNT Position: Q2 2021 in Review

Fidelity Investments sold out of Opiant Pharmaceuticals, Inc. Common Stock (OPNT) in Q2 2021, closing a stake of 200 shares — an estimated $2K sold.

Fidelity Investments first reported a position in OPNT in Q1 2019 and held it in 7 quarters. The position peaked at $2K in Q1 2021. 26 funds tracked by Wall St. Rank hold OPNT as of Q2 2021.

Fidelity Investments reported no remaining Opiant Pharmaceuticals, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
Fidelity Investments sold 200 Opiant Pharmaceuticals, Inc. Common Stock shares in Q2 2021, an estimated $2K.
Fidelity Investments first reported a position in Opiant Pharmaceuticals, Inc. Common Stock in Q1 2019 and held it in 7 quarters.
Fidelity Investments's Opiant Pharmaceuticals, Inc. Common Stock position peaked at $2K in Q1 2021.
26 funds tracked by Wall St. Rank held Opiant Pharmaceuticals, Inc. Common Stock as of Q2 2021.

Based on Fidelity Investments's 13F filing for Q2 2021, filed 13 Aug 2021.